摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-benzyl-2-(4'-chlorophenylazo)imidazole | 189178-23-2

中文名称
——
中文别名
——
英文名称
1-benzyl-2-(4'-chlorophenylazo)imidazole
英文别名
1-benzyl-2-(4-chloro-phenylazo)imidazole;1-benzyl-2-(p-chlorophenylazo)imidazole;1-benzyl-2-(p-Cl-C6H4-NN)imidazole;ClaaiBz;1-Benzyl-2-[(E)-(4-chlorophenyl)diazenyl]-1H-imidazole;(1-benzylimidazol-2-yl)-(4-chlorophenyl)diazene
1-benzyl-2-(4'-chlorophenylazo)imidazole化学式
CAS
189178-23-2
化学式
C16H13ClN4
mdl
——
分子量
296.759
InChiKey
AOOXTHRHXPYQOR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    42.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Ruthenium(II) complexes of α-diimines: synthesis, spectral characterisation, electrochemical properties and single-crystal X-ray structure of bis(2,2′-bipyridine){1-benzyl-2-(p-tollylazo)imidazole}ruthenium(II) perchlorate
    作者:Sanjib Pal、Tarun K. Misra、Chittaranjan Sinha、Alexander M.Z. Slawin、J.Derek Woollins
    DOI:10.1016/s0277-5387(00)00447-2
    日期:2000.9
    [Ru(bpy)2(RaaiR′)](ClO4)2·H2O (bpy=2,2′-bipyridine; RaaiR′=1-alkyl-2-(arylazo)imidazole) have been synthesized by a silver-assisted route [Ru(bpy)2Cl2+RaaiR′+AgNO3+NaClO4/Ru(bpy)2Cl2+[Ag(RaaiR′)2](ClO4)]. The structures of the complexes have been supported by the single-crystal X-ray diffraction study and the stereochemistry are assessed by 1H NMR spectral data. All the complexes show two metal-to-ligand charge
    摘要混合配体三螯合物[Ru(bpy)2(RaaiR')](ClO4)2·H2O(bpy = 2,2'-联吡啶; RaaiR'= 1-烷基-2-(芳基偶氮)咪唑)具有通过辅助路线[Ru(bpy)2Cl2 + RaaiR'+ AgNO3 + Na / Ru(bpy)2Cl2 + [Ag(RaaiR')2]( )]合成。配合物的结构已得到单晶X射线衍射研究的支持,并通过1 H NMR光谱数据评估了立体化学。所有的络合物在约200nm的可见光区域均显示出两个属至配体的电荷转移(MLCT)跃迁。此处还介绍了400和500 nm及其发射光谱。循环伏安研究显示,乙腈溶液中RuIII / II的电势较高(1.4 V vs. SCE),并且在SCE呈负值时连续出现三个配体还原。第一属和后续配体氧化还原电势的差异与MLCT谱带的νCT线性相关。
  • Synthesis and multinuclear NMR investigation on gold(III)-triphenylphosphine-pentafluorophenyl-arylazoimidazole
    作者:P. Byabartta
    DOI:10.1134/s1070328409040046
    日期:2009.4
    Reaction of [Au(C6F5)(PPh3)(OSO2CF3)2] with RaaiR′ in dichloromethane medium followed ligand addition leads to [Au(PPh3)(C6F5)(RaaiR′)](OSO2CF3)2 where RaaiR′ = p-R-C6H4-N=N-C3H2-NN-1-R′ (I–III), abbreviated as N, N′-chelator, where N(imidazole) and N(azo) represent N and N′, respectively; R = H (a), Me (b), Cl (c) and R′ = Me (I), CH2CH3 (II), CH2Ph (III), PPh3 is triphenylphosphine, OSO2CF3 is the
    [Au(C 6 F 5)(PPh 3)(OSO 2 CF 3)2 ]与RaaiR'在二氯甲烷介质中的反应,然后进行配体添加,生成[Au(PPh 3)(C 6 F 5)(RaaiR')] (OSO 2 CF 3)2,其中RaaiR'= p -RC 6 H 4 -N = NC 3 H 2 -NN-1-R'(I–III),缩写为N,N'-螯合剂,其中N(咪唑)和N(偶氮)分别代表N和N';R = H(a),Me(b),Cl(c)和R'= Me(I),CH 2 CH 3(II),CH2 Ph(III),PPh 3是三苯基膦,OSO 2 CF 3是三氟甲磺酸根阴离子。在ESI质谱图中观察到相应分子的最大分子峰。配合物的红外光谱显示-C = N-和-N = N-由于三苯基膦三苯基膦的存在而在〜1590和1370 cm -1附近以及在〜1100、755、695、545和505 cm -1附近拉伸。五氟苯环。的1个1
  • Palladium(II)-dppe-arylazoimidazole complexes: Synthesis, and spectroscopic characterization
    作者:Prithwiraj Byabartta
    DOI:10.1134/s0036023610070107
    日期:2010.7
    Reaction of [Pd(dppe)Cl-2/Br-2] with AgOTf in a dichloromethane medium followed by ligand addition led to [Pd(dppe)(OSO2CF3)(2)] and then [Pd(dppe)(RaaiR)](OSO2CF3)(2) [RaaiR' = p-R-C6H4-N=N-C3H2-NN-1-R', (1-3), abbreviated as a N,N'-chelator, where N(imidazole) and N(azo) are represented by N and N', respectively; R = H (a), Me (b), Cl (c) and R' = Me (1), CH2CH3 (2), CH2Ph (3), OSO2CF3 is the triflate anion, dppe = 1,2-bis-(diphenylphosphinoethane)]. P-31 "H-1" NMR confirmed that due to the two phosphorus atom interaction in the azoimine symmetrical environment one sharp peak was formed. The H-1 NMR spectral measurements suggest that azo-imine link with lot of phenyl protons in the aromatic region. C-13 (H-1) NMR spectrum, H-1, H-1 COSY and H-1, C-13 HMQC spectrum assign the solution structure and stereo-retentive conformation in each complex.
  • Misra; Das; Sinha, Indian Journal of Chemistry, Section A: Inorganic, Physical, Theoretical and Analytical, 1998, vol. 37, # 8, p. 739 - 742
    作者:Misra、Das、Sinha
    DOI:——
    日期:——
  • Gold(III)-chloro-diphenylphosphinoammine-arylazoimidazole complexes: Synthesis, spectroscopic and redox study
    作者:Prithwiraj Byabartta
    DOI:10.1016/j.molstruc.2007.03.014
    日期:2008.2
    The complex [Au-III(dppa)Cl-2(tht)(4)](OSO2CF3), with ligand addition produce [Au-III(dppa)Cl-2(RaaiR')(2)](OTf)(4) [RaaiR'=p-R-C-6 H-4-N=N-C3H2 -NN-1-R', (1-3), abbreviated as N,N'-chelator, where N(imidazole) and N(azo) represent N and N', respectively; R = H (a), Me (b), Cl (c) and R' = Me (1), CH2CH3 (2), CH2Ph (3), dppa is diphenylphosphinoamine, OSO2CF3 is triflate anion, tht is tetrahydrothiophen]. IR spectra of the complexes show -C=N- and -N=N- stretching near at 1590 and 1370 cm(-1) and near at 1100, 755, 695, 545, 505 cm-1 for dppa. The H-1 NMR spectral measurements suggest methylene, -CH2-, in [Au-2(dppa)Cl-2(RaaiCH(2)CH(3))(2)](4+), giving a complex AB type multiplet splitting while in [Au-2(dppa)Cl-2(RaaiCH(2)Ph)(2)](4+), AB type quartet splitting. C-13 (H-1) NMR spectrum suggest the molecular skeleton. Electrochemistry show the ligand reductions at the negative to SCE. (c) 2007 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫